Biofrontera AG buy krebskrebs
Start price
16.08.21
/
50%
€2.49
Target price
16.08.22
€4.00
Performance (%)
-50.80%
End price
17.08.22
€1.23
Summary
This prediction ended on 17.08.22 with a price of €1.23. The BUY prediction by krebskrebs for Biofrontera AG performed very badly with a performance of -50.80%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biofrontera AG | - | - | - | - |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % | 61,27 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % | 90,63 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % | 67,98 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % | 62,52 % |
Comments by krebskrebs for this prediction
In the thread Biofrontera AG diskutieren
In the thread Trading Biofrontera AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten